Myricetin induces apoptosis and enhances chemosensitivity in ovarian cancer cells.


Ovarian cancer is the most lethal type of gynecological cancer and is the fifth leading cause of cancer-associated mortality in females globally. The majority of patients with ovarian cancer suffer from recurrent, progressive disease, due to the acquisition of a resistance phenotype towards various conventional chemotherapy drugs. Although paclitaxel has… (More)
DOI: 10.3892/ol.2017.6031


  • Presentations referencing similar topics